Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/8607
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOlver, Ian N.en
dc.contributor.authorPaska, W.en
dc.contributor.authorDepierre, A.en
dc.contributor.authorSeitz, J. F.en
dc.contributor.authorStewart, D. J.en
dc.contributor.authorGoedhals, L.en
dc.contributor.authorMcQuade, B.en
dc.contributor.authorMcRae, J.en
dc.contributor.authorWilkinson, J. R.en
dc.date.issued1996en
dc.identifier.citationAnnals of Oncology, 1996; 7(9):945-752en
dc.identifier.issn0923-7534en
dc.identifier.urihttp://hdl.handle.net/2440/8607-
dc.description.abstractThe purpose of this study was to investigate the efficacy and safety of oral ondansetron, given alone or in combination with dexamethasone in the control of cisplatin-induced delayed emesis.en
dc.description.statementofresponsibilityI. Olver, W. Paska, A. Depierre, J.-F. Seitz, D. J. Stewart, L. Goedhals, B. McQuade,J. McRae & J. R. Wilkinson on behalf of the Ondansetron Delayed Emesis Study Groupen
dc.language.isoenen
dc.subjectcisplatin, delayed emesis and nausea, dexa-methasone, ondansetron, 5-HT3 receptor antagonisten
dc.titleA multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesisen
dc.typeJournal articleen
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.